MELLO
About:
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
Website: https://mello.bio/
Top Investors: BioInnovation Institute, BioInnovation Institute Venture House
Description:
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics. The company aims to overcome a number of industry-wide challenges which currently prevent optimizing probiotic benefits.
Total Funding Amount:
500000 EUR
Headquarters Location:
Copenhagen, Hovedstaden, Denmark
Founded Date:
2019-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-03-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai